Clinical Trials Directory

Trials / Completed

CompletedNCT01120730

Fluid Resuscitation With HES 200/0.5 10% in Severe Burn Injury

Status
Completed
Phase
Phase 3
Study type
Interventional
Enrollment
28 (actual)
Sponsor
University of Zurich · Academic / Other
Sex
All
Age
18 Years – 80 Years
Healthy volunteers
Not accepted

Summary

HES 200/0.5 10% is equal to ringers lactat solution.

Detailed description

30 Patients were enrolled to the study, either to the hyperoncotic HES 200/0.5 (10%) group or to the crystalloids only group. After a treatment protocol of 72 hours we collected data about complications like pulmonary failure and abdominal compartment syndrome. Furthermore, we addressed the question of incidence of mortality and renal failure.

Conditions

Interventions

TypeNameDescription
DRUGfluid resuscitationfluid resuscitation with HES
DRUGFluid resuscitationFluid resuscitation in standardized fashion

Timeline

Start date
1997-04-01
Primary completion
1998-09-01
Completion
2009-03-01
First posted
2010-05-11
Last updated
2010-05-11

Locations

1 site across 1 country: Switzerland

Source: ClinicalTrials.gov record NCT01120730. Inclusion in this directory is not an endorsement.